For the quarter ended September 30, 2026, Kimball Electronics reported net sales of $390.8 million, a 7% increase year-over-year, though net income fell significantly to $2.6 million from $10.1 million due to higher operating expenses and a sharp increase in the provision for income taxes. The company also completed a major acquisition during the period, resulting in a substantial increase in goodwill and long-term debt.
Kimball Electronics reported 7% revenue growth driven by medical strength and the Health-Way acquisition, while reiterating FY2027 guidance at the high end despite margin pressure from facility ramps and high tax rates.
Kimball Electronics reported Q1 fiscal 2027 net sales of $390.8 million, a 7% year-over-year increase driven by 14% growth in the Medical vertical. The company reiterated its full-year fiscal 2027 guidance, noting that sales are expected to reach the high end of the $1,535 - $1,560 million range.
Term
Q1 2027
“I’m encouraged by our first quarter results and solid start to fiscal 2027. Sales increased both sequentially and year-over-year, margins were healthy, and cash conversion days were once again at a multiyear low. The top line benefited from organic sales growth and the contribution from Helvoet Polymer Technologies, our recent tuck-in acquisition in the medical CDMO.”